Rights and permissions
About this article
Cite this article
Isoniazid cost saving vs rifampicin/pyrazinamide in latent TB. Inpharma Wkly. 1427, 7 (2004). https://doi.org/10.2165/00128413-200414270-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414270-00011